NCT06196879Phase 2Completed

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

Study sponsor: Upstream Bio Inc. · UPB

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-12-16Actual
Enrollment · participants479Actual
Source updated2026-05-01Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 2 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 19 Feb 2026. After: 16 Dec 2025.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview